We are live on ! Find out more
MBII

Marrone Bio Innovations, Inc.
MBII

Delisted

MBII was delisted on the 12th of July, 2022.

Back to rankings

62 hedge funds and large institutions have $45M invested in Marrone Bio Innovations, Inc. in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 12 increasing their positions, 18 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3% less capital invested

Capital invested by funds: $46.4M → $45M (-$1.43M)

13% less funds holding

Funds holding: 71 → 62 (-9)

33% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 18

36% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 22

Holders
62
Holders Change
-9
Holders Change %
-12.68%
% of All Funds
1.04%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
14
Increased
12
Reduced
18
Closed
22
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GLAM
Gardner Lewis Asset Management
Pennsylvania
+$1.35M
2
Millennium Management
Millennium Management
New York
+$1.29M
3
OFA
Oak Family Advisors
Illinois
+$518K
4
E
Ergoteles
New York
+$475K
5
EFI
EHP Funds Inc
Canada
+$319K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$4.55M
2
Geode Capital Management
Geode Capital Management
Massachusetts
-$728K
3
Northern Trust
Northern Trust
Illinois
-$726K
4
UBS Group
UBS Group
Switzerland
-$651K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$566K
Name Holding Trade Value Shares
Change 		Change in
Stake
LP
26
LMR Partners
United Kingdom
$56K +$50.3K +48,156 New
BCV
27
Banque Cantonale Vaudoise
Switzerland
$53K – – –
HF
28
HRT Financial
New York
$44K +$40.3K +38,542 New
BFM
29
Boothbay Fund Management
New York
$42K +$37.7K +36,057 New
YIH
30
Y-Intercept (HK)
Hong Kong
$42K +$38.2K +36,537 New
Victory Capital Management
31
Victory Capital Management
Texas
$28K +$555 +531 +2%
Balyasny Asset Management
32
Balyasny Asset Management
Illinois
$27K +$24.4K +23,350 New
KLCM
33
KG&L Capital Management
Louisiana
$26K – – –
DC
34
Diametric Capital
Massachusetts
$26K +$23.6K +22,590 New
BNP Paribas Financial Markets
35
BNP Paribas Financial Markets
France
$24.4K +$12.7K +12,127 +136%
FIA
36
FNY Investment Advisers
New York
$23K -$26.1K -25,000 -56%
Creative Planning
37
Creative Planning
Kansas
$20K +$17.6K +16,855 New
PCM
38
Prelude Capital Management
New York
$14K +$12.2K +11,705 New
9WM
39
9258 Wealth Management
Ohio
$12K – – –
AWM
40
Apollon Wealth Management
South Carolina
$12K – – –
BG
41
Bahl & Gaynor
Ohio
$12K – – –
Cetera Investment Advisers
42
Cetera Investment Advisers
Illinois
$12K – – –
Northwestern Mutual Wealth Management
43
Northwestern Mutual Wealth Management
Wisconsin
$12K +$10.5K +10,000 New
AWM
44
Avior Wealth Management
Nebraska
$11K – – –
CSS
45
Cubist Systematic Strategies
Connecticut
$11K +$9.71K +9,288 New
Legal & General Group
46
Legal & General Group
United Kingdom
$9K -$3.15K -3,010 -27%
Citigroup
47
Citigroup
New York
$9K +$533 +510 +7%
Osaic Holdings
48
Osaic Holdings
Arizona
$7K – – –
Wells Fargo
49
Wells Fargo
California
$4K -$65.7K -62,852 -95%
TRCT
50
Tower Research Capital (TRC)
New York
$3K -$9.46K -9,051 -81%
1
2
3 4

MBII Hedge Fund Activity: Q2 2022 in Review

62 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q2 2022, worth a combined $45M — down 3.1% from $46.4M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of MBII and 14 opened new positions — a net loss of 8 holders — while 18 trimmed existing stakes and 12 added.

The largest buyer was Gardner Lewis Asset Management, adding an estimated $1.35M. The largest seller was BlackRock, cutting an estimated $4.55M.

  • 62 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q2 2022, down from 71 in Q1 2022.
  • Funds reported $45M of Marrone Bio Innovations, Inc. stock for Q2 2022, down 3.1% quarter-over-quarter.
  • 14 funds opened new Marrone Bio Innovations, Inc. positions in Q2 2022 and 22 closed out, a net change of -8 holders.
  • The largest Marrone Bio Innovations, Inc. buyer in Q2 2022 was Gardner Lewis Asset Management, an estimated $1.35M added.
  • The largest Marrone Bio Innovations, Inc. seller in Q2 2022 was BlackRock, an estimated $4.55M sold.

Based on aggregated 13F filings for Q2 2022.